TrialBlood advances2026

RENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma.

Barbara Botto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.